FDA Approves Generic Version of Xalatan® Eye Drops for Glaucoma
April 4, 2011
Mylan Inc. today announced that the FDA has approved its Latanoprost Ophthalmic Solution, 0.005%, a generic version of Xalatan® eye drops for treatment of glaucoma.
The product represents Mylan’s first ophthalmic solution.
Click here for the full press release.
Jump down to form below to submit your own comments